PFIZER ZOLOFT SALES ARE $638.4 MIL. IN U.S. IN 1994 AS FIRM POSTS 13% DOMESTIC Rx SALES GROWTH; GENENTECH's PULMOZYME SALES ARE $88.3 MIL. IN FIRST YEAR
Pfizer's antidepressant Zoloft recorded sales of $638.4 mil. in the U.S. in 1994, a lofty 50% increase over the previous year, Pfizer reported Jan. 18.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth